Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal

C. Hershko, S. Avramovici-Grisaru, G. Link, L. Gelfand, S. Sarel

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Abstract

The source of iron chelated in vivo by the new iron-chelating agent PIH and its mechanism of excretion have been studied in normal and hypertransfused rats. PIH is able to chelate iron from both parenchymal and RE iron stores. Unlike DF, which promotes both urinary and fecal iron excretion, in this model PIH-induced iron excretion is limited almost entirely to the gut. Response to PIH is directly related to dosage, and oral doses ranging from 125 to 500 mg/kg/day are well tolerated. Six additional imino derivatives of pyridoxal have been studied, but none of these new compounds was as effective as PIH. Our study indicates that oral PIH is comparable in efficiency with parenteral DF and is of potential usefulness in the management of iron overload.

Original languageAmerican English
Pages (from-to)99-108
Number of pages10
JournalTranslational Research
Volume98
Issue number1
StatePublished - Jul 1981

Fingerprint

Dive into the research topics of 'Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal'. Together they form a unique fingerprint.

Cite this